Exact Sciences Corp (NAS:EXAS)
$ 53.52 2.52 (4.94%) Market Cap: 9.88 Bil Enterprise Value: 11.78 Bil PE Ratio: 0 PB Ratio: 3.14 GF Score: 78/100

Exact Sciences Corp at Jefferies London Healthcare Conference (Virtual) Transcript

Nov 16, 2021 / 03:40PM GMT
Release Date Price: $91.48 (+1.68%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

All right. Great. Thanks, everybody, for being here in person and sticking with us. Good afternoon. Welcome to the London 2021 Healthcare Conference. I'm Brandon Couillard. I cover tools and diagnostics here at the firm. Very excited to have Exact Sciences with us back at the conference this year. Here to introduce a little bit of the story, then we'll jump into some Q&A., COO and CFO, Jeff Elliott; as well as Head of IR, Megan Jones, in the back, so over to you, Jeff.

Jeffrey T. Elliott
Exact Sciences Corporation - Executive VP, CFO & COO

Thanks, Brandon, and thanks to Jefferies for having us. I can't tell you how great it is to be back into a room full of people again. Hopefully, we can keep doing this forever now.

Here's our safe harbor, please read it closely. For those of you who don't know who Exact Sciences is, we are a leading global advanced cancer diagnostics company. Our 2 main products you may have heard of, Cologuard for colon cancer screening and the Oncotype,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot